We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
BlogFrom theory to therapy in the genome editing boom
Genome editing has been riding the wave of hype for some time, but is genuinely making its way into healthcare
BlogPlans for paid-for NHS genome sequencing shelved
In a laudable policy decision to listen to concerns raised by the genomics community, plans for paying ‘genomic volunteers’ to receive NHS whole genome sequencing have been dropped.
BlogFirst gene silencing drug offered on NHS
A new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the National Health Service (NHS) in England.
BlogGenomic test in infectious disease
Medical student, Simran Goyal, investigated point of care medical devices for infectious diseases whilst on placement at the PHG Foundation. Here she sets out what she found
BlogCancer screening services of the future
An interim report from the independent review of cancer screening was published last week. Dr Laura Blackburn reviews its findings so far.
BlogCan genomic medicine attract, recruit and retain clinical bioinformaticians?
Policy briefingSomatic genome editing: an overview
The development of the CRISPR system has brought genome editing into the spotlight